SCHEMBL8219490

SCHEMBL8219490

CCOC(=O)c1cnc(-c2cc(F)cc(F)c2)cc1Cc1cc(OC)ccc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
THRB P10828 1/20 0.43
ALDH1A1 P00352 7/20 0.41
KDM4E B2RXH2 3/20 0.41
CYP1A2 P05177 1/20 0.41
HPGD P15428 2/20 0.40
LMNA P02545 3/20 0.39
GAA P10253 1/20 0.39
PTGDR Q13258 1/20 0.39
MAPK1 P28482 1/20 0.38
CDC7 O00311 1/20 0.38
DBF4 Q9UBU7 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NMT1 P30419 1/20 0.38
TP53 P04637 1/20 0.37
CSNK1D P48730 1/20 0.37
JMJD6 Q6NYC1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3343610 0.83 CYP1A2 (0.43) MAPTSMN1; SMN2THRBALDH1A1KDM4E
SCHEMBL8216214 0.82 KDM4E (0.39) MAPTSMN1; SMN2THRBKDM4ECYP1A2
SCHEMBL3344136 0.79 BAZ2B (0.46) MAPTSMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL3343855 0.72 MAPT (0.44) MAPTSMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL8217024 0.71 RAB9A (0.41) SMN1; SMN2LMNA
SCHEMBL8221375 0.71 KMO (0.43) MAPTSMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL3341192 0.71 ALDH1A1 (0.54) MAPTSMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL3340085 0.71 KMO (0.40) SMN1; SMN2KDM4ELMNAMEN1KMT2A
SCHEMBL3341133 0.71 JAK2 (0.53) MAPTSMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL544894 0.68 MAPT (0.62) MAPTSMN1; SMN2THRBALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008031500-A1 4-PHENOXY-NICOTINE ACID DERIVATIVES AND USE THEREOF AS PPAR-MODULATORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-20 WO disclosed